Literature DB >> 19099273

[Polymyalgia rheumatica].

C Duftner1, C Dejaco, M Schirmer.   

Abstract

Polymyalgia rheumatica (PMR) is a common chronic inflammatory rheumatic disease with unknown aetiology, affecting predominately people of middle age and older. Besides clinical symptoms and diagnostics, imaging techniques including sonography and magnetic resonance imaging may provide evidence of typical inflammatory lesions with bilateral bursitis subdeltoidea or subacromialis, tenosynovitis of the biceps tendon sheath and/or synovitis of the shoulder joints and thus may support the diagnosis of this disease in difficult cases. Corticosteroids are the cornerstone of treatment of PMR, but adverse events because of chronic corticosteroid use are observed in more than 50% of treated patients. Whether immunosuppressants, such as methotrexate and tumour necrosis factor-alpha inhibitors are effective in the therapy of PMR has still not yet been clarified.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19099273     DOI: 10.1007/s00108-008-2274-x

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  20 in total

1.  Long-term follow-up of polymyalgia rheumatica: evidence for synovitis.

Authors:  L A Healey
Journal:  Semin Arthritis Rheum       Date:  1984-05       Impact factor: 5.532

2.  Shoulder ultrasonography in the diagnosis of polymyalgia rheumatica: a case-control study.

Authors:  F Cantini; C Salvarani; I Olivieri; L Niccoli; A Padula; L Macchioni; L Boiardi; G Ciancio; M Mastrorosato; F Rubini; A Bozza; G Zanfranceschi
Journal:  J Rheumatol       Date:  2001-05       Impact factor: 4.666

3.  Acute-phase reactants and the risk of relapse/recurrence in polymyalgia rheumatica: a prospective followup study.

Authors:  Carlo Salvarani; Fabrizio Cantini; Laura Niccoli; Pierluigi Macchioni; Dario Consonni; Gianluigi Bajocchi; Marco Vinceti; Maria Grazia Catanoso; Lia Pulsatelli; Riccardo Meliconi; Luigi Boiardi
Journal:  Arthritis Rheum       Date:  2005-02-15

4.  Infliximab plus prednisone or placebo plus prednisone for the initial treatment of polymyalgia rheumatica: a randomized trial.

Authors:  Carlo Salvarani; PierLuigi Macchioni; Carlo Manzini; Giuseppe Paolazzi; Aldo Trotta; Paolo Manganelli; Marco Cimmino; Roberto Gerli; Maria Grazia Catanoso; Luigi Boiardi; Fabrizio Cantini; Catherine Klersy; Gene G Hunder
Journal:  Ann Intern Med       Date:  2007-05-01       Impact factor: 25.391

5.  Clinical utility of anti-CCP antibodies in the differential diagnosis of elderly-onset rheumatoid arthritis and polymyalgia rheumatica.

Authors:  M Lopez-Hoyos; C Ruiz de Alegria; R Blanco; J Crespo; M Peña; V Rodriguez-Valverde; V M Martinez-Taboada
Journal:  Rheumatology (Oxford)       Date:  2004-02-17       Impact factor: 7.580

6.  Polymyalgia rheumatica: a 10-year epidemiologic and clinical study.

Authors:  T Y Chuang; G G Hunder; D M Ilstrup; L T Kurland
Journal:  Ann Intern Med       Date:  1982-11       Impact factor: 25.391

7.  Prednisone plus methotrexate for polymyalgia rheumatica: a randomized, double-blind, placebo-controlled trial.

Authors:  Roberto Caporali; Marco A Cimmino; Gianfranco Ferraccioli; Roberto Gerli; Catherine Klersy; Carlo Salvarani; Carlomaurizio Montecucco
Journal:  Ann Intern Med       Date:  2004-10-05       Impact factor: 25.391

8.  Polymyalgia rheumatica and giant cell arteritis: a 5-year epidemiologic and clinical study in Reggio Emilia, Italy.

Authors:  C Salvarani; P L Macchioni; P L Tartoni; F Rossi; R Baricchi; C Castri; F Chiaravalloti; I Portioli
Journal:  Clin Exp Rheumatol       Date:  1987 Jul-Sep       Impact factor: 4.473

Review 9.  Vascular dendritic cells in giant cell arteritis.

Authors:  Cornelia M Weyand; Wei Ma-Krupa; Olga Pryshchep; Stefan Gröschel; Roberto Bernardino; Jörg J Goronzy
Journal:  Ann N Y Acad Sci       Date:  2005-12       Impact factor: 5.691

10.  An evaluation of criteria for polymyalgia rheumatica.

Authors:  H A Bird; W Esselinckx; A S Dixon; A G Mowat; P H Wood
Journal:  Ann Rheum Dis       Date:  1979-10       Impact factor: 19.103

View more
  2 in total

Review 1.  [Diagnostics and treatment of polymyalgia rheumatica].

Authors:  C Dejaco; E L Matteson; F Buttgereit
Journal:  Z Rheumatol       Date:  2016-09       Impact factor: 1.372

Review 2.  Definition of remission and relapse in polymyalgia rheumatica: data from a literature search compared with a Delphi-based expert consensus.

Authors:  Christian Dejaco; Christina Duftner; Marco A Cimmino; Bhaskar Dasgupta; Carlo Salvarani; Cynthia S Crowson; Hilal Maradit-Kremers; Andrew Hutchings; Eric L Matteson; Michael Schirmer
Journal:  Ann Rheum Dis       Date:  2010-11-19       Impact factor: 19.103

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.